Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 16

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

433

WORD

286

HTML

3843

Tables (1-2)

174

Sum=4736

Publishing Process of This Article

Item

Count

Browse

794

Download

756

Sum=1550

Apr 28, 2014 (publication date) through Jul 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Apr 28, 2014; 20(16): 4516-4525
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4516

Table 2 GASTRIC group meta-analysis[10]

Studies (n)		Comparison	Pooled HR (95%CI)
For OS analysis	For DFS analysis¹		OS	DFS
17	14	Comparison	Overall	0.82 (0.76-0.90)	0.82 (0.75-0.90)
2	1	Mono Chemotherapy vs surgery	0.60 (0.40-0.84)	0.49 (0.29-0.84)
3	2	Fluorouracil + mitomycin C + other without anthracyclines vs surgery	0.74 (0.58-0.95)	0.69 (0.48-0.98)
3	2	Fluorouracil + mitomycin C + anthracyclines vs surgery	0.82 (0.71-0.95)	0.80 (0.69-0.94)

Citation: Miceli R, Tomasello G, Bregni G, Bartolomeo MD, Pietrantonio F. Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges. World J Gastroenterol 2014; 20(16): 4516-4525
URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4516.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4516